Lonza Group (OTCMKTS:LZAGY) Sees Large Volume Increase – Here’s Why

Lonza Group Ag (OTCMKTS:LZAGY) saw unusually-high trading volume on Wednesday . Approximately 132,358 shares changed hands during trading, an increase of 96% from the previous session’s volume of 67,653 shares.The stock last traded at $65.6850 and had previously closed at $67.15.

Analysts Set New Price Targets

Separately, Zacks Research lowered Lonza Group from a “hold” rating to a “strong sell” rating in a report on Wednesday, February 4th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Lonza Group has a consensus rating of “Sell”.

Lonza Group Stock Performance

The company’s 50 day simple moving average is $68.13 and its 200-day simple moving average is $68.55. The company has a quick ratio of 0.87, a current ratio of 1.46 and a debt-to-equity ratio of 0.48.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.